Cavelier, M.; Gondé, H.; Costa, D.; Lamoureux, F.; Pereira, T.; Buchbinder, N.; Varin, R.; Hervouët, C.
Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension. Pharmaceutics 2023, 15, 446.
https://doi.org/10.3390/pharmaceutics15020446
AMA Style
Cavelier M, Gondé H, Costa D, Lamoureux F, Pereira T, Buchbinder N, Varin R, Hervouët C.
Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension. Pharmaceutics. 2023; 15(2):446.
https://doi.org/10.3390/pharmaceutics15020446
Chicago/Turabian Style
Cavelier, Marine, Henri Gondé, Damien Costa, Fabien Lamoureux, Tony Pereira, Nimrod Buchbinder, Rémi Varin, and Charles Hervouët.
2023. "Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension" Pharmaceutics 15, no. 2: 446.
https://doi.org/10.3390/pharmaceutics15020446
APA Style
Cavelier, M., Gondé, H., Costa, D., Lamoureux, F., Pereira, T., Buchbinder, N., Varin, R., & Hervouët, C.
(2023). Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension. Pharmaceutics, 15(2), 446.
https://doi.org/10.3390/pharmaceutics15020446